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Abstract
Silver amalgam/Silverfil Argentum® is a ‘Malaysian made amalgam’ has already been approved to be free
from cytotoxicity, however its genotoxic effect has not been explored yet as biocompatible material. The
objective of this study was to identify the genotoxic characteristic of silver amalgam by using Bacterial Reverse
Mutation Assay (Ames test). This was a descriptive experimental study involving one strain of mutated
Salmonella. The test material was evaluated in one mutated strain of Salmonella typhimurium TA1538 with
and without an external metabolic activation system (S9 Mix). The bacteria were incubated for 48 hours at
37±0.5ºC before the colony growth or revertant colonies were counted. Data obtained were analyzed by
using non-statistical method. The investigation of the genotoxic reaction on the test material revealed that
the number of revertant colonies in both strains with and without S9 Mix were less than twice of the negative
control even in the presence of high silver amalgam concentrations (5.0µg/ml). This study demonstrated
that the test material did not exhibit any mutagenic activity under the chosen conditions. Thus, silver amalgam
could be considered to have no genotoxicity effect.
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successfully received FDA 510 (K) clearance for
cytotoxicity from the United States Department of
Health and Services in America1.
An international standard2 lays down specific
requirements for biocompatibility, including the tests
based on the nature of the contact and the duration
of implantation of the biomaterial. The standard
stipulates that all materials that will be in contact
with mucous membrane, bone or dentinal tissue
where the contact exceeds 30 days, as well as all
implantable devices where the contact exceeds 24
hours, must undergo genotoxicity testing3.
1. Introduction
Dental amalgam was recognized to be the most long
lasting restorative material in dentistry ever been
made until now. In spite of good hardness properties,
level of toxicity of mercury content is keep declining
over the years. Many companies of amalgam product
passionately running in research and put full effort
in order to notify their product to be free from
mutagenesis.
Silver amalgam/Silverfil Argentum® is a Malaysian
made amalgam developed since 13 years ago has
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According to ISO 10993-3 [2] when the genetic
toxicity of a medical device has to be experimentally
assessed, a series of in vitro tests shall be used, this
series shall include at least three assays and at least
two of these should preferably use mammalian cells
as a target.
Kirkpatrick et al. 4 and Katzer et al. 5 suggested
using an in vitro study after allowing for cost intensive
and time consuming. Moltelmans and Zeiger6
strongly agreed that Salmonella typhymurium/
microsome assay to be widely accepted as a short-
term bacterial assay in order to identify the substance
that can produce genetic damage that leads to gene
mutations.
To reduce the number of biomechanical studies,
evaluation of new biomaterials should nowadays
begin with in vitro cytotoxicity and mutagenicity
tests. This applies for the development of both
temporary and permanent implants and prostheses
and for permanent implant particularly under the
aspect that carcinogenic potential is often the
consequence of chronic exposure to minute
concentrations 5.
Although silver amalgam had successfully
explored in cytotoxic effect studies, the genotoxic
characteristics have to be carried out before it can
be known as biocompatible material.
Therefore, the aim of this study was to identify
the genotoxicity effect of silver amalgam by using
Bacterial Reverse Mutation Assay (Ames test).
2. Material and Methods
2.1 Study design and sample size
This was a descriptive experimental study using Ames
test. The test was conducted in Ames laboratory in
School of Dental Sciences, Universiti Sains Malaysia.
No sample size required in this study. Replication of
2-3 plates for each positive & negative control and
the test substance with different doses with and
without metabolic activation (S9 Mix) were taken
base on previous study7. The Salmonella
typhimurium which was then stored as frozen stock
culture.
2.2 Test substance
Silver amalgam/ Silverfil Argentum® was supplied by
Dunia Perwira Manufacturing Sdn. Bhd. and available
in capsule form. In preparation of the tested material,
the capsule containing silver amalgam was triturated
by using amalgamator for 5 seconds. The bolus was
let to be dried and hardened before it could be
powderized. The powder was weighted into 5 unit
of scale of 5000µg/2500µg/1250µg/625µg/313µg per
plate respectively by using micro weight machine (mg
scale). Each unit scale of powder was then diluted
into 1 ml of distilled water and kept inside incubator
for 24 hours at 37±0.5°C rolling prior to the
procedure.
2.3 Negative and positive controls
The negative control used in this study was sterile
distilled water8. Specific positive controls were used
in order to confirm the reversion properties and the
specificity of each tester strain and the efficacy of
the metabolic activation system. Toxic positive
control application caused genotoxic effect (reverse
mutation) to bacterial strains. Positive control
chemicals were specifically designed as highly
mutagenic to each strain. For strain TA1538, 4-Nitro-
o-phenylenediamine was applied without S-9 Mix
(which was replaced by sodium phosphate buffer).
On other hand, 2- Aminoantracene (2AA) was used
in S-9 Mix inclusion6.
2.4 Tester strain
Basically, this test uses a number of Salmonella
strains with preexisting mutation that leave the
bacteria unable to synthesize the required amino
acid, histidine and therefore unable to grow onto
histidine-free agar. Once being exposed to the
mutagens, it will revert and allow the cells to
synthesized histidine and become histidine
independent that make it able to grow and form a
colony on the same plate5. Here, TA1538 was selected
strains used under samples 471 approved by
International Organization for Standardization 2.
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Genetically, TA1538 was going to be for detection
of frameshift mutation [8]. This strain was obtained
from Dr. T. Nohmi from National Institute of Health
Science, Tokyo, Japan and was stored as frozen stock
cultures (0.035ml of DMSO / 0.4ml of broth culture)
at -80±5°C in ultra-deep freezer (MDF 392AT,
SANYO). Therefore, reviving this two strain before
use are very important particularly for genetic
analysis.
Reviving or frozen working culture process began
with inoculation of 1 ml of Salmonella typhimurium
into 5 ml of nutrient broth and a nutrient agar plate.
This procedure was done in a ‘Lamina Flow’. This two
medium was then incubated for overnight in the
incubator (SANYO) at 37±0.5°C. The result was shown
Figure 1. Procedure for Ames test
cloudy-look in nutrient broth and colonies were
formed on the nutrient agar. One isolated healthy
colony was transferred and streaked onto Glucose
Minimal (GM) agar and incubated for 48 hours at
37±0.5°C. This would later produced colony and
subculture was repeated for another 48 hours. The
last colony formed on the GM agar so-called master
plate was being run for genetic analysis by streaking
the bacteria onto histidine, biotin and histidine-biotin
filled agar for 15 hours6-8. There was no growth seen
in histidine and biotin agar but presence on histine-
biotin agar. rfa marker had shown growth inhibition
which proved that TA1538 was mutated on specific
genotype. After underwent genetic analysis, TA1538
was ready to be used.
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2.5 Medium and S9 Mix
Minimal glucose agar plate was supplied by Oriental
Yeast Co. Ltd., Japan and consisted of following
components: X20 Vogel-Bonner minimum medium
E (50 ml/L), 40 w/v % glucose (50ml/L) and Agar
(Bacto-Agar, Difco Laboratories) (15g/L). Soft agar
containing 0.5 mM histidine and 0.5 mM biotin for
S. typhimurium strains or 0.5 mM tryptophan for E.
coli strain was added to soft agar solution containing
0.6 w/v %  agar ( Bacto-Agar, Difco Laboratories ) and
0.5 w/v % NaCl in a ratio of 1:10. S9 Mix was supplied
by Kikkoman Co. Ltd., Japan. One ml of S9 Mix
contains protein ( 25.19 mg/ml ), cytochrome P-450
(0.97 nmol/mg protein), DMN demethylase activity
( 4.97 nmol HCHO formed/mg protein/min), aniline
hydroxylase activity ( 24.02 nmol p-aminophenol
formed/mg protein/hr ) and B [a] P hydroxylase
activity  ( 16.85 times higher than non induced S9 ).
2.6 Procedures
After 0.1 ml of the test substance solution, 0.5 ml of
0.1 M sodium phosphate buffer (pH 7.4) or S9 Mix
and 0.1 ml of the bacterial culture were added to a
tube, the mixture were incubated 20 minutes at 37
± 0.5°C. 2 ml of soft agar was then added to each
tube and poured onto a minimal glucose agar plate.
After incubation for 48 hours at 37 ± 5°C, the number
of revertant colonies was counted. As for the sterility
test, 0.1 ml of test substance solution, S9 Mix and
0.1 M sodium phosphate buffer (pH 7.4) were poured
onto a minimal glucose agar plate and incubated at
37 ± 0.5°C for 48 hours to check for the bacterial
contamination. Pure water was used as negative
control and the following positive controls were used
for bacterial strain.
2.7 Colony counting
The number of  colonies  were  counted  with  a
manual  counter  or  a  colony  analyzer ( ProtoCol ).
Each plate was counted three times and the average
of the three counts was adopted as the number of
revertant colonies on the plate. The average number
of revertant colonies for each dose was calculated
as the average plate count for a set of duplicate.
Decimals of the average figures were rounded off.
2.8 Interpretation of the results
Signs of toxicity or growth inhibition for all the
bacterial strains under the test condition was
described in this report. The test substance was
judged to be negative, when the number of revertant
colonies was less than twice that of the negative
control.
2.9 Analysis (Non Statistical Procedures)
For this study, a non-statistical procedure was used
to evaluate the results of Salmonella experiments [6].
Positive: A compound is considered a mutagen if it
produces a reproducible, dose-related increase in the
number of revertant colonies in one or more strains.
A minimum  fold  increase,  usually  2–3  fold,  in
revertants  (over  the  solvent  control)  is  the  cut-
off   between   a mutagenic and nonmutagenic
response. A compound is considered a weak mutagen
if it produces a reproducible, dose-related increase
in the number of revertant colonies in one or more
strains but the number of revertants is not double
of the background. Negative:  A compound is
considered a nonmutagen if no dose-related increase
in the number of revertant colonies is observed in at
least two independent experiments. Inconclusive: If
a compound cannot be identified clearly as a
mutagen or a nonmutagen, the results are classified
as inconclusive.
3. Results
The test substance is considered to be mutagenic
when the number of counted colonies exceeds the
number of colonies in the negative controls by at
least double and a relationship between dose and
response can be observed 6.
The results showed the numbers of revertant
colonies which were treated with the test substance
were less than twice of negative control with and
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without S9 Mix at all concentrations presented both
in tables and figures. No dose-response relationship
was obtained and no statistical procedure was used.
The results in the Salmonella tester strains are
presented in Table 1 and 2 and shown in Figure 2
and 3.
4. Discussion
In order to protect the human health, every single
materials that need to be exposed to the human for
example dental materials need to be confirmed
safely. Based on International Standard, [2], all
medical device shall be tested for genotoxicity except
those made only from materials known to show no
genotoxicity effect. There was approximately eight
different in vitro assays are listed down for
researchers to choose. However, the best two tests
would be Organization for Economic Cooperation and
Development (OECD) tests which were Salmonella
typhimurium reverse mutation assay (471) and
mammalian cytogenetic test (473)8,9. In this study,
the assay used was Salmonella typhimurium reverse
mutation alone and it showed very significant
findings.
Generally, a negative result can be defined using
4-5 strains. However, a single strain is sufficient to
demonstrate a mutagenic response. Strains TA98,
TA100, TA97 and TA1537 are always considered
necessary. Besides, other strains such as TA102,
TA104, TA1535 and TA1538 are also widely used.
Although all known assays can yield false-positive
and false-negative results, experience shows that the
combination of two different test methods is a
reliable parameter for determining  carcinogens
which  are  a  risk  to  human  health 5.
Concentrations of silver amalgam with a range
from 313mg to 5000mg were chosen as standard
values given by Mortelmans and Zeiger6, because this
material has been previously approved to be out of
cytotoxic effect and yet the 5000mg was the highest
indicator value to respond to any genotoxic activity.
To ensure the comparabi lity of results, the
extraction temperature should preferably be 37+
0.5°C that mimicked the human body temperature
and the time must be at least 24 hours 10. Silver
amalgam was dissolved into distilled water and not
DMSO simply because DMSO solution is known to
be highly cytotoxic.
This study involves the mixture of S9 as metabolic
activation system because Salmonella typhymurium
is only a prokaryote (basic cell living structure) and
cannot represent the human being as a perfect
model; therefore the addition of the exogenous liver
enzyme could enhance the quality of the result.
The top agar is the most critical medium
components in Ames test because it contains the
trace amount of histidine (0.05 mM) for limited
growth of Salmonella strains. It also contains biotin
at a concentration of 0.05 mM which is in excess of
what is needed for the growth of Salmonella strains.
Too much histidine will cause heavy growth that may
obsecure the revertant colonies 6.
After 48 hours incubated, the revertants colonies
of Salmonella typhymurium were counted by using
Computerized Colony Analyzer (ProtoCol.). The
specificity and sensitivity was fixed to 96% with 8 cm
diameter of countered area. This measurement was
done homogenously to all plates.
In the future, in vitro genotoxicity test which will
preferably use more strains and mammalian cells as
target should be carried out. In vivo genotoxicity test
can be undertaken if scientifically indicated or in vitro
test results indicate potential genotoxicity. A
nanotechnology measurement technique hopefully
can be applied to cut the tester material into more
identical size according to reference doses.
5. Conclusion
In conclusion, these data were demonstrating as
negative result and showing the test materials did
not exhibit mutagenic activity and no dose-related
increase in the number of revertant colonies under
the present test conditions. Thus, the material was
considered to have no genotoxic effect.
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